Corvò R - Search Results

1

Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational study.

Ricardi U, Frezza G, Filippi AR, Badellino S, Levis M, Navarria P, Salvi F, Marcenaro M, Trovò M, Guarneri A, Corvò R, Scorsetti M. Ricardi U, et al. Among authors: corvo r. Lung Cancer. 2014 Jun;84(3):248-53. doi: 10.1016/j.lungcan.2014.02.015. Epub 2014 Mar 13. Lung Cancer. 2014. PMID: 24681279 Free article.

2

Ablative or palliative stereotactic body radiotherapy with helical tomotherapy for primary or metastatic lung tumor.

Marcenaro M, Vagge S, Belgioia L, Agnese D, Lamanna G, Mantero E, Gusinu M, Garelli S, Cavagnetto F, Agostinelli S, Corvò R. Marcenaro M, et al. Among authors: corvo r. Anticancer Res. 2013 Feb;33(2):655-60. Anticancer Res. 2013. PMID: 23393363 Clinical Trial.

3

Excellent survival regardless of disease stage in patients with advanced nasopharyngeal cancer.

Belgioia L, Bacigalupo A, Vecchio S, Marcenaro M, Pupillo F, Agostinelli S, Corvò R. Belgioia L, et al. Among authors: corvo r. Tumori. 2016 Aug 3;102(4):381-6. doi: 10.5301/tj.5000483. Epub 2016 Apr 7. Tumori. 2016. PMID: 27056334

4

Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity.

Arcangeli S, Jereczek-Fossa BA, Alongi F, Aristei C, Becherini C, Belgioia L, Buglione M, Caravatta L, D'Angelillo RM, Filippi AR, Fiore M, Genovesi D, Greco C, Livi L, Magrini SM, Marvaso G, Mazzola R, Meattini I, Merlotti A, Palumbo I, Pergolizzi S, Ramella S, Ricardi U, Russi E, Trovò M, Sindoni A, Valentini V, Corvò R. Arcangeli S, et al. Among authors: corvo r. Crit Rev Oncol Hematol. 2019 Feb;134:104-119. doi: 10.1016/j.critrevonc.2018.11.006. Epub 2018 Nov 30. Crit Rev Oncol Hematol. 2019. PMID: 30658887 Review.

5

Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice.

Barra S, Guarnieri A, di Monale E Bastia MB, Marcenaro M, Tornari E, Belgioia L, Magrini SM, Ricardi U, Corvò R. Barra S, et al. Among authors: corvo r. Radiol Med. 2021 Jan;126(1):142-146. doi: 10.1007/s11547-020-01216-9. Epub 2020 May 15. Radiol Med. 2021. PMID: 32415472 Free PMC article.

6

A phase II trial of low-dose gemcitabine and radiation alternated to cisplatin and 5-fluorouracil: an active and manageable regimen for stage IV squamous cell carcinoma of the head and neck.

Benasso M, Vigo V, Bacigalupo A, Ponzanelli A, Marcenaro M, Corvò R, Margarino G. Benasso M, et al. Among authors: corvo r. Radiother Oncol. 2008 Oct;89(1):44-50. doi: 10.1016/j.radonc.2008.04.002. Radiother Oncol. 2008. PMID: 18423671 Clinical Trial.

7

Prolonged complete remission after induction chemotherapy followed by chemoradiation with tomotherapy in metastatic nasopharyngeal cancer.

Agnese D, Belgioia L, Bacigalupo A, Marcenaro M, Vecchio S, Agostinelli S, Morbelli S, Corvò R. Agnese D, et al. Among authors: corvo r. Anticancer Res. 2014 Sep;34(9):5075-8. Anticancer Res. 2014. PMID: 25202093

8

Kidney-sparing radiotherapy by multiple-field three-dimensional technique in the postoperative management of patients with gastric cancer: comparison with standard two-field conformal technique.

Marcenaro M, Foppiano F, Durzu S, Barra S, Corvò R. Marcenaro M, et al. Among authors: corvo r. Tumori. 2006 Jan-Feb;92(1):34-40. doi: 10.1177/030089160609200107. Tumori. 2006. PMID: 16683382

9

Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated carcinoma of the nasopharynx: optimal compliance and promising 4-year results.

Ponzanelli A, Vigo V, Marcenaro M, Bacigalupo A, Gatteschi B, Ravetti JL, Corvò R, Benasso M. Ponzanelli A, et al. Among authors: corvo r. Oral Oncol. 2008 Aug;44(8):767-74. doi: 10.1016/j.oraloncology.2007.09.011. Epub 2007 Dec 3. Oral Oncol. 2008. PMID: 18061519

10

Image guided hypofractionated radiotherapy by helical tomotherapy for prostate carcinoma: toxicity and impact on Nadir PSA.

Barra S, Vagge S, Marcenaro M, Blandino G, Timon G, Vidano G, Agnese D, Gusinu M, Cavagnetto F, Corvò R. Barra S, et al. Among authors: corvo r. Biomed Res Int. 2014;2014:541847. doi: 10.1155/2014/541847. Epub 2014 Mar 18. Biomed Res Int. 2014. PMID: 24745018 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters